Profiling of Invasive Breast Carcinoma Circulating Tumour Cells—Are We Ready for the ‘Liquid’ Revolution?
As dissemination through blood and lymph is the critical step of the metastatic cascade, circulating tumour cells (CTCs) have attracted wide attention as a potential surrogate marker to monitor progression into metastatic disease and response to therapy. In patients with invasive breast carcinoma (I...
Main Authors: | Marcin Braun, Aleksandra Markiewicz, Radzisław Kordek, Rafał Sądej, Hanna Romańska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/2/143 |
Similar Items
-
Clinical significance of circulating tumour cells and Ki-67 in renal cell carcinoma
by: Jinbo Song, et al.
Published: (2021-05-01) -
Biosensors for the Detection of Circulating Tumour Cells
by: Clotilde Costa, et al.
Published: (2014-03-01) -
Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back
by: Luis León-Mateos, et al.
Published: (2016-09-01) -
The challenges of detecting circulating tumour cells in sarcoma
by: Marta Tellez-Gabriel, et al.
Published: (2016-09-01) -
Capture of Circulating Tumour Cell Clusters Using Straight Microfluidic Chips
by: Arutha Kulasinghe, et al.
Published: (2019-01-01)